Chinese Journal of Cancerindexed by SCI
《癌症》杂志
BMC

About the cover

pISSN: 1000-467X

eISSN: 1944-446X

CN: 44-1195/R

 

View OnlineFirst Articles

New articles accepted recently

View Current Issue

Volume 36 Issue 10

Browse Past Issues

From January 2002


1 Low expression of centrosomal protein 78 (CEP78) is associated with poor prognosis of colorectal cancer patients
     Meifang Zhang, Tingmei Duan, Li Wang, Jianjun Tang, Rongzhen Luo, Ruhua Zhang and Tiebang Kang
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-10   Downloaded: 2085
2 Attenuated LKB1-SIK1 signaling promotes epithelial-mesenchymal transition and radioresistance of non–small cell lung cancer cells
     Yuan-Hu Yao, Yan Cui, Xiang-Nan Qiu, Long-Zhen Zhang, Wei Zhang, Hao Li and Jin-Ming Yu
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-10   Downloaded: 2019
3 Chromatin remodeling factor LSH affects fumarate hydratase as a cancer driver
     Shuang Liu and Yong-Guang Tao
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-10   Downloaded: 1592
4 Chemotherapy in non-small cell lung cancer: opportunities for advancement
     Mani Akhtari, Eric H. Bernicker and Bin S. Teh
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-9   Downloaded: 1800
5 Cell-free circulating tumor DNA in cancer
     Zhen Qin, Vladimir A. Ljubimov, Cuiqi Zhou, Yunguang Tong and Jimin Liang
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-5   Downloaded: 3678
6 Altered expression of stromal interaction molecule (STIM)-calcium release-activated calcium channel protein (ORAI) and inositol 1,4,5-trisphosphate receptors (IP3Rs) in cancer: will they become a new battlefield for oncotherapy?
     Jing Wen, Ying-Cheng Huang, Huan-Huan Xiu, Zhi-Ming Shan and Kang-Qing Xu
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-5   Downloaded: 4136



1 Mechanisms of vascularization in murine models of primary and metastatic tumor growth
     Edina Bugyik, Ferenc Renyi-Vamos, Vanessza Szabo, Katalin Dezso, Nora Ecker, Andras Rokusz, Peter Nagy, Balazs Dome and Sandor Paku
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-2   Downloaded: 5991
2 Trabectedin therapy as an emerging treatment strategy for recurrent platinum-sensitive ovarian cancer
     José Antonio López-Guerrero, Ignacio Romero, Andrés Poveda
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2015-1   Downloaded: 5467
3 Ovarian cancer standard of care: are there real alternatives?
     Chiara Della Pepa, Giuseppe Tonini, Carmela Pisano, Marilena Di Napoli, Sabrina Chiara Cecere, Rosa Tambaro, Gaetano Facchini, Sando Pignata
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2015-1   Downloaded: 4736
4 Altered expression of stromal interaction molecule (STIM)-calcium release-activated calcium channel protein (ORAI) and inositol 1,4,5-trisphosphate receptors (IP3Rs) in cancer: will they become a new battlefield for oncotherapy?
     Jing Wen, Ying-Cheng Huang, Huan-Huan Xiu, Zhi-Ming Shan and Kang-Qing Xu
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-5   Downloaded: 4136
5 Cell-free circulating tumor DNA in cancer
     Zhen Qin, Vladimir A. Ljubimov, Cuiqi Zhou, Yunguang Tong and Jimin Liang
     [ Abstract ] [ PDF Full-text ] [ PubMed]   2016-5   Downloaded: 3678



Gastric cancer  

 

Edited by Yun Dai and Li Yan
 

This thematic series discusses the molecular classifications of gastric cancer by the Cancer Genome Atlas (TCGA) and the Asian Cancer Research Group (ACRG) as well as the implications in personalized therapeutic choices; discusses the evolution of gastric surgery and presents perspectives on surgical techniques in treating gastric cancer; and reviews current and emerging targeted agents as well as immunotherapies in treating gastric cancer. With these advancements in molecular characterization, surgical intervention, and targeted and immunotherapies, gastric cancer will enter a personalized medicine era in the next 5 years.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Tumor angiogenesis  

 

Edited by Francesco Pezzella
and Chao-Nan Qian 

Forming efficient vasculature network, also known as tumor angiogenesis, is a critical hallmark in tumor development. Explorations on its underlying molecular mechanisms have resulted in several novel anti-cancer drugs. However, the modest survival benefits from anti-angiogenic therapy have forced us to revisit our understanding on tumor angiogenesis. In this special issue, world-leading experts have contributed their critical thoughts to reveal alternative tumor angiogenesis approaches and potential treatment targets.

 

Read thematic series > 

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 

Lung cancer 


 

Edited by Lin Yan and Wei Zhang  

 

Lung cancer accounts for approximately 21% of worldwide cancer deaths and a staggering 1.6 million new cases are diagnosed every year. In China, lung cancer has become a particularly challenging disease because of air pollution and smoking. This thematic series discusses the proper use of targeted agents in treating lung cancer, reviews the application of biomarkers in clinical management and drug development, and analyzes the unique challenges in developing novel drugs for lung cancer in China.

 

Read thematic series > 



CJC Wechat 微信公众号

CJC触屏版


 

Editorial Manager


CJC adopts Editorial Manager to manage its submissions from Dec.18, 2014
 

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CJC is now published by BioMed Central

© Chinese Journal of Cancer

ICP 备案序号:粤ICP备12079158号

Sun Yat-sen University Cancer Center

651 Dongfeng Road East,Guangzhou 510060, P.R.China